View ValuationThis company listing is no longer activeThis company may still be operating, however this listing is no longer active. Find out why through their latest events.See Latest EventsECMOHO 将来の成長Future 基準チェック /06主要情報n/a収益成長率n/aEPS成長率Online Retail 収益成長0%収益成長率n/a将来の株主資本利益率n/aアナリストカバレッジNone最終更新日n/a今後の成長に関する最新情報お知らせ • Nov 06ECMOHO Limited Provides Earnings Guidance for the Third Quarter of 2022ECMOHO Limited provided earnings guidance for the third quarter of 2022. For the quarter, The company expects that the net loss will decrease in the third quarter of 2022, compared with the same quarter of last year.お知らせ • Sep 02ECMOHO Limited Provides Preliminary Earnings Guidance for the Third Quarter of 2021ECMOHO Limited provided preliminary earnings guidance for the third quarter of 2021. For the quarter, the company expects net loss to be significantly decrease.すべての更新を表示Recent updatesお知らせ • Nov 06ECMOHO Limited Provides Earnings Guidance for the Third Quarter of 2022ECMOHO Limited provided earnings guidance for the third quarter of 2022. For the quarter, The company expects that the net loss will decrease in the third quarter of 2022, compared with the same quarter of last year.お知らせ • Oct 27Nasdaq Stock Market to Delist the American Depositary Shares of Ecmoho LimitedOn October 26, 2022, Nasdaq Stock Market announced that it will delist the American Depositary Shares of ECMOHO Limited. ECMOHO Limited’s securities were suspended on September 23, 2022, and have not traded on Nasdaq since that time. Nasdaq will file a Form 25 with the Securities and Exchange Commission to complete the delisting. The delisting become effective ten days after the Form 25 is filed.Board Change • Jul 29Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Director Fang Yuan was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Board Change • Apr 27Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Director Fang Yuan was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Buying Opportunity • Feb 26Now 97% undervalued after recent price dropOver the last 90 days, the stock is down 100%. The fair value is estimated to be US$0.016, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has grown by 33% per annum over the last 3 years.Reported Earnings • Dec 01Third quarter 2021 earnings: Revenues in line with analyst expectationsThird quarter 2021 results: Revenue: US$28.3m (down 61% from 3Q 2020). Net loss: US$3.75m (loss narrowed 9.0% from 3Q 2020). Revenue was in line with analyst estimates.お知らせ • Sep 23ECMOHO Limited Announces Receipt of Minimum Bid Price Notice from NasdaqECMOHO Limited announced that it received a notification letter dated September 16, 2021 (the “Deficiency Letter”) from the Listing Qualifications Department of The Nasdaq Stock Market Inc. (the “Nasdaq”), indicating that the Company is no longer in compliance with the minimum bid price requirement set forth in Rule 5450(a)(1) of the Nasdaq Listing Rules as the Company’s closing bid price per American depositary share (“ADS”), each representing four Class A ordinary shares, par value $0.00001 per share, of the Company, has been below $1.00 for a period of 30 consecutive business days. The Nasdaq notification letter does not result in the immediate delisting of the Company's securities. Pursuant to Rule 5810(c)(3)(A) of the Nasdaq Listing Rules, the Company has a compliance period of 180 calendar days, or until March 15, 2022 (the “Compliance Period”), to regain compliance with Nasdaq's minimum bid price requirement. If at any time during the Compliance Period, the closing bid price per ADS is at least $1.00 for a minimum of 10 consecutive business days, Nasdaq will provide the Company a written confirmation of compliance and the matter will be closed. In the event that the Company does not regain compliance by March 15, 2022, subject to the determination by the staff of Nasdaq, it may be eligible for an additional 180 calendar days compliance period if it meets the continued listing requirements for market value of publicly held shares and all other initial listing standards, with the exception of bid price requirement, of the Nasdaq Capital Market, and provides written notice to Nasdaq of its intention to cure the deficiency.お知らせ • Sep 02ECMOHO Limited Provides Preliminary Earnings Guidance for the Third Quarter of 2021ECMOHO Limited provided preliminary earnings guidance for the third quarter of 2021. For the quarter, the company expects net loss to be significantly decrease.Reported Earnings • Sep 01Second quarter 2021 earnings releasedThe company reported a soft second quarter result with weaker revenues and control over costs, although losses reduced. Second quarter 2021 results: Revenue: CN¥42.8m (down 94% from 2Q 2020). Net loss: CN¥3.56m (loss narrowed 89% from 2Q 2020).お知らせ • Aug 05ECMOHO Limited has completed a Follow-on Equity Offering in the amount of $9 million.ECMOHO Limited has completed a Follow-on Equity Offering in the amount of $9 million. Security Name: American Depositary Shares Security Type: Depositary Receipt (Common Stock) Securities Offered: 10,000,000 Price\Range: $0.9 Discount Per Security: $0.063Reported Earnings • Jun 05First quarter 2021 earnings releasedThe company reported a poor first quarter result with increased losses, weaker revenues and weaker control over costs. First quarter 2021 results: Revenue: US$27.1m (down 56% from 1Q 2020). Net loss: US$6.07m (loss widened 38% from 1Q 2020).お知らせ • May 18Ecmoho Limited and Harbin Pharmaceutical Group Announce Joint Launch of New Iron Supplement ProductECMOHO Limited announced that on May 10, 2021, a new product, Puxue Oral Liquid, which is a supplement intended for use by children aged between one and 17, adults, pregnant women, and nursing mothers who suffer from iron and vitamin B12 deficiencies, is jointly launched by the Company and Harbin Pharmaceutical Group Co. Ltd. (“HPGC”). ECMOHO is primarily responsible for the packaging design and sales distribution of the new product.Reported Earnings • May 03Full year 2020 earnings releasedThe company reported a poor full year result with weaker earnings, revenues and control over costs. Full year 2020 results: Revenue: US$304.9m (down 7.4% from FY 2019). Net loss: US$13.3m (down US$14.3m from profit in FY 2019). このセクションでは通常、投資家が会社の利益創出能力を理解する一助となるよう、プロのアナリストのコンセンサス予想に基づく収益と利益の成長予測を提示する。しかし、ECMOHO は十分な過去のデータを提供しておらず、アナリストの予測もないため、過去のデータを外挿したり、アナリストの予測を使用しても、その将来の収益を確実に算出することはできません。 シンプリー・ウォール・ストリートがカバーする企業の97%は過去の財務データを持っているため、これはかなり稀な状況です。 業績と収益の成長予測DB:0NE - アナリストの将来予測と過去の財務データ ( )USD Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数6/30/202295-49N/AN/AN/A3/31/2022121-51N/AN/AN/A12/31/2021131-5644N/A9/30/2021170-14N/AN/AN/A6/30/2021213-14N/AN/AN/A3/31/2021271-15N/AN/AN/A12/31/2020305-132122N/A9/30/2020336-14N/AN/AN/A6/30/2020340-9N/AN/AN/A3/31/2020327-3N/AN/AN/A12/31/20193291-15-14N/A9/30/20193056N/AN/AN/A6/30/2019279-20-52-50N/A3/31/2019227-21N/AN/AN/A12/31/2018199-22-43-41N/A12/31/201798-1-3-2N/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: 0NEの予測収益成長が 貯蓄率 ( 0.2% ) を上回っているかどうかを判断するにはデータが不十分です。収益対市場: 0NEの収益がGerman市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です高成長収益: 0NEの収益が今後 3 年間で 大幅に 増加すると予想されるかどうかを判断するにはデータが不十分です。収益対市場: 0NEの収益がGerman市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。高い収益成長: 0NEの収益が年間20%よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。一株当たり利益成長率予想将来の株主資本利益率将来のROE: 0NEの 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です成長企業の発掘7D1Y7D1Y7D1YRetail 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2023/03/07 07:47終値2022/12/14 00:00収益2022/06/30年間収益2021/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋ECMOHO Limited これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
お知らせ • Nov 06ECMOHO Limited Provides Earnings Guidance for the Third Quarter of 2022ECMOHO Limited provided earnings guidance for the third quarter of 2022. For the quarter, The company expects that the net loss will decrease in the third quarter of 2022, compared with the same quarter of last year.
お知らせ • Sep 02ECMOHO Limited Provides Preliminary Earnings Guidance for the Third Quarter of 2021ECMOHO Limited provided preliminary earnings guidance for the third quarter of 2021. For the quarter, the company expects net loss to be significantly decrease.
お知らせ • Nov 06ECMOHO Limited Provides Earnings Guidance for the Third Quarter of 2022ECMOHO Limited provided earnings guidance for the third quarter of 2022. For the quarter, The company expects that the net loss will decrease in the third quarter of 2022, compared with the same quarter of last year.
お知らせ • Oct 27Nasdaq Stock Market to Delist the American Depositary Shares of Ecmoho LimitedOn October 26, 2022, Nasdaq Stock Market announced that it will delist the American Depositary Shares of ECMOHO Limited. ECMOHO Limited’s securities were suspended on September 23, 2022, and have not traded on Nasdaq since that time. Nasdaq will file a Form 25 with the Securities and Exchange Commission to complete the delisting. The delisting become effective ten days after the Form 25 is filed.
Board Change • Jul 29Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Director Fang Yuan was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Board Change • Apr 27Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Director Fang Yuan was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Buying Opportunity • Feb 26Now 97% undervalued after recent price dropOver the last 90 days, the stock is down 100%. The fair value is estimated to be US$0.016, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has grown by 33% per annum over the last 3 years.
Reported Earnings • Dec 01Third quarter 2021 earnings: Revenues in line with analyst expectationsThird quarter 2021 results: Revenue: US$28.3m (down 61% from 3Q 2020). Net loss: US$3.75m (loss narrowed 9.0% from 3Q 2020). Revenue was in line with analyst estimates.
お知らせ • Sep 23ECMOHO Limited Announces Receipt of Minimum Bid Price Notice from NasdaqECMOHO Limited announced that it received a notification letter dated September 16, 2021 (the “Deficiency Letter”) from the Listing Qualifications Department of The Nasdaq Stock Market Inc. (the “Nasdaq”), indicating that the Company is no longer in compliance with the minimum bid price requirement set forth in Rule 5450(a)(1) of the Nasdaq Listing Rules as the Company’s closing bid price per American depositary share (“ADS”), each representing four Class A ordinary shares, par value $0.00001 per share, of the Company, has been below $1.00 for a period of 30 consecutive business days. The Nasdaq notification letter does not result in the immediate delisting of the Company's securities. Pursuant to Rule 5810(c)(3)(A) of the Nasdaq Listing Rules, the Company has a compliance period of 180 calendar days, or until March 15, 2022 (the “Compliance Period”), to regain compliance with Nasdaq's minimum bid price requirement. If at any time during the Compliance Period, the closing bid price per ADS is at least $1.00 for a minimum of 10 consecutive business days, Nasdaq will provide the Company a written confirmation of compliance and the matter will be closed. In the event that the Company does not regain compliance by March 15, 2022, subject to the determination by the staff of Nasdaq, it may be eligible for an additional 180 calendar days compliance period if it meets the continued listing requirements for market value of publicly held shares and all other initial listing standards, with the exception of bid price requirement, of the Nasdaq Capital Market, and provides written notice to Nasdaq of its intention to cure the deficiency.
お知らせ • Sep 02ECMOHO Limited Provides Preliminary Earnings Guidance for the Third Quarter of 2021ECMOHO Limited provided preliminary earnings guidance for the third quarter of 2021. For the quarter, the company expects net loss to be significantly decrease.
Reported Earnings • Sep 01Second quarter 2021 earnings releasedThe company reported a soft second quarter result with weaker revenues and control over costs, although losses reduced. Second quarter 2021 results: Revenue: CN¥42.8m (down 94% from 2Q 2020). Net loss: CN¥3.56m (loss narrowed 89% from 2Q 2020).
お知らせ • Aug 05ECMOHO Limited has completed a Follow-on Equity Offering in the amount of $9 million.ECMOHO Limited has completed a Follow-on Equity Offering in the amount of $9 million. Security Name: American Depositary Shares Security Type: Depositary Receipt (Common Stock) Securities Offered: 10,000,000 Price\Range: $0.9 Discount Per Security: $0.063
Reported Earnings • Jun 05First quarter 2021 earnings releasedThe company reported a poor first quarter result with increased losses, weaker revenues and weaker control over costs. First quarter 2021 results: Revenue: US$27.1m (down 56% from 1Q 2020). Net loss: US$6.07m (loss widened 38% from 1Q 2020).
お知らせ • May 18Ecmoho Limited and Harbin Pharmaceutical Group Announce Joint Launch of New Iron Supplement ProductECMOHO Limited announced that on May 10, 2021, a new product, Puxue Oral Liquid, which is a supplement intended for use by children aged between one and 17, adults, pregnant women, and nursing mothers who suffer from iron and vitamin B12 deficiencies, is jointly launched by the Company and Harbin Pharmaceutical Group Co. Ltd. (“HPGC”). ECMOHO is primarily responsible for the packaging design and sales distribution of the new product.
Reported Earnings • May 03Full year 2020 earnings releasedThe company reported a poor full year result with weaker earnings, revenues and control over costs. Full year 2020 results: Revenue: US$304.9m (down 7.4% from FY 2019). Net loss: US$13.3m (down US$14.3m from profit in FY 2019).